IP Library › Assignment 022484/0699
Patent Assignment
Reel/Frame 022484/0699

Assignment of Assignor's Interest

Recorded: 2009-04-01 Pages: 7
Assignor
OCTOPLUS SCIENCES B.V.
Executed: 2008-10-03
Assignee
BIOLEX THERAPEUTICS, INC.
158 CREDLE STREET, PITTSBORO, NORTH CAROLINA, 27312
Covered Properties (2)
Controlled Release Interferon Drug Products and Treatment of Hcv Infection Using Same
Controlled Release Interferon Drug Products and Treatment of Hcv Infections Using Same
Patent: 8,137,661 →
Application: 12/180,214 →
Publication: US 2009/0068280
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Termination of Security Interest Oct 14, 2008
From: S.R. ONE, LIMITED; LSP III OMNI INVESTMENT COOPERATIEF U.A.
To: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
Reel/Frame 021691/0034 →
Termination of Security Interest Oct 14, 2008
From: BIOLEX THERAPEUTICS, INC.
To: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
Reel/Frame 021701/0168 →
Assignment of Assignor's Interest Dec 5, 2008
From: SPENCER, DAVID GELVIN, JR.; HUMPHRIES, JOHN ELLIOTT
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 021930/0148 →
Assignment of Assignor's Interest Dec 5, 2008
From: DE LEEDE, LEONARDUS GERARDUS JOZEF; VERRIJK, RUDOLF
To: OCTOPLUS SCIENCES BV
Reel/Frame 021930/0176 →
Security Agreement Nov 9, 2010
From: BIOLEX THERAPEUTICS, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 025333/0026 →